Evidence map›Paper›PMID 34732270›Full record

ArticleEpidemiology and infection2021

The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).

Benido Impouma, Franck Mboussou, Bridget Farham, Caitlin M Wolfe, Krys Johnson, Catherine Clary, Richard Mihigo, Ngoy Nsenga, Ambrose Talisuna, Zabulon Yoti and 5 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. COVID-19 impacts on healthcare access in sub-Saharan Africa: an overview.The journal of venomous animals and toxins including tropical diseases · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Benido ImpoumaWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.ORCID 0000-0001-6363-7146
Franck MboussouWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Bridget FarhamWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.ORCID 0000-0001-5463-0858
Caitlin M WolfeWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Krys JohnsonWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.ORCID 0000-0002-1437-1879
Catherine ClaryWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Richard MihigoWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Ngoy NsengaWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Ambrose TalisunaWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Zabulon YotiWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Antoine FlahaultInstitute of Global Health, University of Geneva, Geneva, Switzerland.
Olivia KeiserInstitute of Global Health, University of Geneva, Geneva, Switzerland.
Abdou Salam GueyeWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Joseph CaboreWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Matshidiso MoetiWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The World Health Organization African region recorded its first laboratory-confirmed coronavirus disease-2019 (COVID-19) cases on 25 February 2020. Two months later, all the 47 countries of the region were affected. The first anniversary of the pandemic occurred in a changed context with the emergence of new variants of concern (VOC) and growing COVID-19 fatigue. This study describes the epidemiological trajectory of COVID-19 in the region, summarises public health and social measures (PHSM) implemented and discusses their impact on the pandemic trajectory. As of 24 February 2021, the African region accounted for 2.5% of cases and 2.9% of deaths reported globally. Of the 13 countries that submitted detailed line listing of cases, the proportion of cases with at least one co-morbid condition was estimated at 3.3% of all cases. Hypertension, diabetes and human immunodeficiency virus (HIV) infection were the most common comorbid conditions, accounting for 11.1%, 7.1% and 5.0% of cases with comorbidities, respectively. Overall, the case fatality ratio (CFR) in patients with comorbid conditions was higher than in patients without comorbid conditions: 5.5% vs. 1.0% (P < 0.0001). Countries started to implement lockdown measures in early March 2020. This contributed to slow the spread of the pandemic at the early stage while the gradual ease of lockdowns from 20 April 2020 resulted in an upsurge. The second wave of the pandemic, which started in November 2020, coincided with the emergence of the new variants of concern. Only 0.08% of the population from six countries received at least one dose of the COVID-19 vaccine. It is critical to not only learn from the past 12 months to improve the effectiveness of the current response but also to start preparing the health systems for subsequent waves of the current pandemic and future pandemics.

Indexed as

SARS-CoV-2AfricaComorbidityCOVID-19HumansRisk FactorsTime FactorsWorld Health OrganizationAfrican regionCOVID-19pandemic responsepublic health and social measures

Identifiers

PMID34732270
PMCPMC8712926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.